stefano fiorucci

University of Perugia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Bianca Fiorillo

Non-tenured Assistant Professor-RTDA

University of Naples Federico II

ITALY

View details

Cristina Di Giorgio

University of Perugia

ITALY

View details

Bruno Catalanotti

Assistant Professor

University of Naples Federico II

ITALY

View details

Angela Zampella

ITALY

View details

Claudia Finamore

University of Naples Federico II

ITALY

View details

Vittorio Limongelli

Full Professor

Università del Salento

SWITZERLAND

View details

Simona De Marino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

stefano fiorucci

Research Interests

Explore related searches

Contact this professor

Articles (20)

Current Landscape and Evolving Therapies for Primary Biliary Cholangitis

Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis

Preface

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer

Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders

Theonella: A Treasure Trove of Structurally Unique and Biologically Active Sterols

Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists

Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease

Bile Acids and SARS-CoV-2: Ursodeoxycholic Acid as a Potential Treatment of COVID-19

Bile acids and bile acid activated receptors in the treatment of Covid-19

Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease

Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma

Immunomodulatory functions of FXR

GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation

Linking liver metabolic and vascular disease via bile acid signaling

Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury

Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease

Bile Acids Activated Receptors in Inflammatory Bowel Disease

Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation

Collaborators (7)

Bianca Fiorillo

Cristina Di Giorgio

Bruno Catalanotti

Angela Zampella

Claudia Finamore

Vittorio Limongelli

Simona De Marino

Make your next move.